Skip to main content
Livermore
Livermore
ZHEN

Endurant Capital Management LP

SEC CIK
0001633055
Latest filing
May 7, 2024

Holdings in Q4 2023

Holdings as of Dec 31, 2023, filed Feb 14, 2024. Long positions only; changes compare share counts with Q3 2023.

Institution overview
Positions
25
−18 vs. Q3 2023
Portfolio value
$17.4M
−$93.9M (−84.3%) vs. Q3 2023
Filed
Feb 14, 2024
SEC
Holdings of Endurant Capital Management LP in Q4 2023
SecurityClassSharesValue% of portfolioShare changeActionHistory
BSXBoston Scientific CorpStock39,108$2.26M13.0%−8,785−18.3%ReducedHistory
TMOThermo Fisher Scientific Inc.Stock3,794$2.01M11.5%−10,055−72.6%ReducedHistory
AXNXAxonics, Inc.COM24,871$1.55M8.9%+24,871NewHistory
ELVElevance Health, Inc.Stock2,627$1.24M7.1%−10,874−80.5%ReducedHistory
ICLRIcon PLCCOM3,659$1.04M5.9%+3,659NewHistory
LHLabcorp Holdings Inc.COM NEW3,984$905.5K5.2%+3,984NewHistory
EHCEncompass Health CorpCOM12,870$858.7K4.9%+12,870NewHistory
PODDInsulet CorpStock3,906$847.5K4.9%−4,972−56.0%ReducedHistory
HOLXHologic IncCOM11,631$831.0K4.8%−6,119−34.5%ReducedHistory
ZBHZimmer Biomet Holdings, Inc.Stock5,646$687.1K3.9%−11,833−67.7%ReducedHistory
AVTRAvantor, Inc.COM24,598$561.6K3.2%−202,279−89.2%ReducedHistory
THCTenet Healthcare CorpCOM NEW7,303$551.9K3.2%−19,848−73.1%ReducedHistory
PFEPfizer IncStock15,790$454.6K2.6%+15,790NewHistory
BMRNBiomarin Pharmaceutical IncCOM4,650$448.4K2.6%−174,918−97.4%ReducedHistory
KIDSOrthopediatrics CorpCOM13,428$436.5K2.5%−56,936−80.9%ReducedHistory
CICigna GroupStock1,384$414.4K2.4%−4,699−77.2%ReducedHistory
QDELQuidelOrtho CorpCOM5,147$379.3K2.2%−21,600−80.8%ReducedHistory
COOCooper Companies, Inc.COM NEW988$373.9K2.1%−10,545−91.4%ReducedHistory
SBRASabra Health Care REIT, Inc.REIT20,017$285.6K1.6%−183,775−90.2%ReducedHistory
AAgilent Technologies, Inc.COM1,900$264.2K1.5%+1,900NewHistory
FTREFortrea Holdings Inc.COMMON STOCK6,988$243.9K1.4%+6,988NewHistory
QGENQiagen N.V.SHS NEW5,219$226.7K1.3%+5,219NewHistory
HUMHumana IncStock469$214.7K1.2%−6,115−92.9%ReducedHistory
CORCencora, Inc.Stock990$203.3K1.2%−10,616−91.5%ReducedHistory
ACRSAclaris Therapeutics, Inc.COM148,400$155.8K0.9%+148,400NewHistory

Sold out since Q3 2023 (27)

Positions held at the end of Q3 2023 that are gone from this filing.

Positions of Endurant Capital Management LP sold out since Q3 2023
SecurityClassShares in Q3 2023Value in Q3 2023% of portfolio in Q3 2023History
BRKRBruker CorpCOM111,276$6.93M6.2%History
AZNAstraZeneca PLCSPONSORED ADR96,444$6.53M5.9%History
MRKMerck & Co., Inc.Stock44,384$4.57M4.1%History
ARGXArgenx SESPONSORED ADR9,108$4.48M4.0%History
CNMDCONMED CorpCOM41,984$4.23M3.8%History
TXG10x Genomics, Inc.CL A COM71,044$2.93M2.6%History
OHIOmega Healthcare Investors IncCOM80,070$2.66M2.4%History
SYKStryker CorpStock7,547$2.06M1.9%History
INSMINSMED IncCOM PAR $.0179,471$2.01M1.8%History
DXCMDexcom IncCOM20,694$1.93M1.7%History
ABTAbbott LaboratoriesStock18,040$1.75M1.6%History
ETNB89bio, Inc.COM82,153$1.27M1.1%History
OCULOcular Therapeutix, IncCOM353,707$1.11M1.0%History
AZTAAzenta, Inc.COM19,422$974.8K0.9%History
TARSTarsus Pharmaceuticals, Inc.COM47,649$846.7K0.8%History
AHCOAdaptHealth Corp.COMMON STOCK89,937$818.4K0.7%History
AXSMAxsome Therapeutics, Inc.COM11,254$786.5K0.7%History
IQVIQVIA Holdings Inc.Stock3,946$776.4K0.7%History
BLUEbluebird bio, Inc.COM251,785$765.4K0.7%History
OLMAOlema Pharmaceuticals, Inc.COM58,573$723.4K0.6%History
VTYXVentyx Biosciences, Inc.COM18,458$641.0K0.6%History
ACLXArcellx, Inc.COMMON STOCK14,158$508.0K0.5%History
GDRXGoodRx Holdings, Inc.COM CL A87,290$491.4K0.4%History
RNACCartesian Therapeutics, Inc.COM453,314$480.5K0.4%History
iShares Tr46428743220 YR TR BD ETF3,400$301.5K0.3%–
NVSTEnvista Holdings CorpCOM10,787$300.7K0.3%History
ADAPYAdaptimmune Therapeutics PLCSPONDS ADR311,944$243.3K0.2%History